| Company name | Merck & Co., Inc. |
| Stock ticker | MRK |
| Live stock price | [stckqut]MRK[/stckqut] |
| P/E compared to competitors | Good |
MANAGEMENT EXECUTION
| Employee productivity | Good |
| Sales growth | Fair |
| EPS growth | Good |
| P/E growth | Good |
| EBIT growth | Good |
ANALYSIS
| Confident Investor Rating | Good |
| Target stock price (TWCA growth scenario) | $67.23 |
| Target stock price (averages with growth) | $80.66 |
| Target stock price (averages with no growth) | $70.94 |
| Target stock price (manual assumptions) | $64.58 |
The following company description is from Google Finance: http://www.google.com/finance?q=mrk
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. In May 2011, it acquired Inspire Pharmaceuticals, Inc. In September 2011, the Company sold its 50% interest in the Johnson & Johnson-Merck Consumer Pharmaceuticals Company joint venture. In December 2011, the Company established an Asia Research & Development (R&D) headquarters for drug discovery and development located in Beijing, China.
Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.